Abstract |
Frailty, defined as a state of decreased physiologic reserve, has been correlated with poorer outcomes after hospitalization or surgery. Studies in lung transplant patients have associated frailty with an increased risk of post-transplant mortality; however, a unified approach is lacking. The identification of frail patients can help clinicians pre-emptively target modifiable risk factors and may facilitate risk stratification. The Frailty Risk Score (FRS) is a chart review-based approach based on eight symptoms and four laboratory biomarkers. We applied this method in a retrospective study to investigate its utility in predicting post-transplant lung outcomes. Eighty-four lung transplant recipients were evaluated, including 51 older (≥ 60) and 33 younger (< 60) patients. Median FRS score was 3.9, with 63 categorized as frail (75%) and 21 as non-frail (25%), using a previously published cut-off of ≥3 to define frailty. A high FRS was associated with readmission in the first year after transplantation and with the number of readmissions. There was also an association between FRS score and death (p = .047). FRS may be a viable tool in the assessment of lung transplant candidates. Frail patients may benefit from earlier referral and targeted therapy prior to transplant, as well as close post-transplant follow-up.
|
Authors | Serina Gee, Yoon Lee, Aloukika Shah, Ehsan Izadmehr, John Belperio, Yusaku Shino, Sam Weigt, Deena Goldwater, Joanna Schaenman |
Journal | Clinical transplantation
(Clin Transplant)
Vol. 36
Issue 1
Pg. e14461
(01 2022)
ISSN: 1399-0012 [Electronic] Denmark |
PMID | 34486175
(Publication Type: Journal Article)
|
Copyright | © 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Topics |
- Frailty
(diagnosis)
- Humans
- Lung Transplantation
- Retrospective Studies
- Risk Factors
- Transplant Recipients
|